MARKET

ELAN

ELAN

Elanco Animal Health
NYSE

Real-time Quotes | Nasdaq Last Sale

30.83
-0.68
-2.16%
Opening 12:41 10/30 EDT
OPEN
31.51
PREV CLOSE
31.51
HIGH
31.95
LOW
30.79
VOLUME
641.87K
TURNOVER
--
52 WEEK HIGH
34.09
52 WEEK LOW
15.17
MARKET CAP
14.55B
P/E (TTM)
-123.8124
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Elanco to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Credit Suisse 29th Annual Virtual Healthcare Conference on Monday, November 9, 2020. Jeff Simmons, president and CEO, will participate in a virtual fireside chat at 3:30 p.m. ET.
Business Wire · 1d ago
FDA OKs Elanco treatment for weight loss in cats with kidney disease
The FDA approves Elanco Animal Health's (ELAN) Elura (capromorelin oral solution) for the management of weight loss in cats with chronic kidney disease ((CKD)).In a pivotal field study, more than
Seekingalpha · 2d ago
Elancos Elura (capromorelin oral solution) Gains U.S. Approval
With the U.S. Food and Drug Administration (FDA) approval of Elura™ (capromorelin oral solution), a new prescription medication to manage weight loss in cats with chronic kidney disease (CKD), Elanco Animal Health (NYSE: ELAN) expands its feline offerings while addressing an unmet need in an increasingly common condition as cats age.
Business Wire · 2d ago
Elanco Releases Healthy Purpose 2030 Sustainability Commitments to Improve Health of Animals, People and Planet
Elanco Animal Health Incorporated (NYSE: ELAN) today announced its first sustainability commitments, just two years after becoming an independent company. The decade-long commitments support the SDGs, address societal challenges and underscore Elanco’s role in improving the health of animals, which also improves the health of people and the planet.
Business Wire · 3d ago
What To Do After Elanco Returned 66%
Elanco shares trended steadily higher after the last quarterly results.Investors like the market share growth and strong cash flow growth.Downside and upside scenarios discussed.
Seekingalpha · 10/16 10:48
Elanco Recommends Shareholders Reject "Mini-Tender" Offer by TRC Capital Investment Corporation
Elanco Animal Health Incorporated ("Elanco") (NYSE: ELAN) has received a notification of an unsolicited "mini-tender" offer by TRC Capital Investment Corporation ("TRC Capital") to purchase up to 4,000,000 shares of Elanco common stock, representing approximately 1.00% of the outstanding shares of Elanco common stock.
Business Wire · 10/13 20:00
Elanco thumbs down on mini-tender for shares
Elanco Animal Health ([[ELAN]] -2.0%) has been notified an unsolicited “mini-tender” offer by TRC Capital Investment to purchase up to 4M Elanco shares, representing ~1% of the outstanding shares.TRC Capital’s
Seekingalpha · 10/13 19:38
Cramer Shares His Thoughts On NCino, AT&T And More
On CNBC's Mad Money Lightning Round," Jim Cramer said he likes Trane Technologies PLC (NYSE: TT). He thinks it's a buy.
Benzinga · 10/11 15:08
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ELAN. Analyze the recent business situations of Elanco Animal Health through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 16 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ELAN stock price target is 29.56 with a high estimate of 37.00 and a low estimate of 19.00.
EPS
Institutional Holdings
Institutions: 565
Institutional Holdings: 449.19M
% Owned: 95.20%
Shares Outstanding: 471.85M
TypeInstitutionsShares
Increased
109
48.17M
New
126
-3.01M
Decreased
112
54.13M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.83%
Pharmaceuticals & Medical Research
-1.21%
Key Executives
Chairman/Independent Director
R. David Hoover
President/Chief Executive Officer/Director
Jeffrey Simmons
Chief Financial Officer/Executive Vice President
Todd Young
Executive Vice President/General Counsel/Secretary
Michael-Bryant Hicks
Executive Vice President/Director of Human Resources
David Kinard
Executive Vice President/Secretary
Sarena Lin
Executive Vice President
Ramiro Cabral
Executive Vice President
Aaron Schacht
Executive Vice President
David Urbanek
Chief Accounting Officer/Vice President
James Meer
Independent Director
Kapila Anand
Independent Director
John Bilbrey
Independent Director
Art Garcia
Independent Director
Michael Harrington
Independent Director
Deborah Kochevar
Independent Director
Lawrence Kurzius
Independent Director
Kirk McDonald
Independent Director
Carl McMillian
Independent Director
David Ricks
Independent Director
Denise Scots-Knight
Independent Director
Aarti Shah
Independent Director
Joshua Smiley
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ELAN
Elanco Animal Health Incorporated is an animal health company that develops, manufactures and markets products for companion and food animals. The Company offers its products under four primary categories, such as Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. It provides a range of parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. It also offers a pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. It also provides treatments for otitis (ear infections), as well as cardiovascular and dermatology indications. Its portfolio in Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics. It also provides products in poultry and aquaculture production.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Elanco Animal Health Inc stock information, including NYSE:ELAN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ELAN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ELAN stock methods without spending real money on the virtual paper trading platform.